Exelixis, Inc.
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…
Biotechnology
US, Alameda [HQ]
Balance Sheet
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 343.00 | 360.00 | 393.00 | 721.00 | 503.00 | 327.00 | 332.00 | 597.00 | 655.00 | 1,422.00 | 1,885.00 | 2,137.00 | 2,616.00 | 3,071.00 | 2,942.00 | |
|
Current
|
230.00 | 183.00 | 228.00 | 432.00 | 266.00 | 167.00 | 178.00 | 470.00 | 484.00 | 897.00 | 1,011.00 | 1,445.00 | 1,834.00 | 1,618.00 | 1,317.00 | |
| Cash And Equivalents | 86.00 | 97.00 | 74.00 | 170.00 | 103.00 | 80.00 | 141.00 | 151.00 | 183.00 | 314.00 | 266.00 | 319.00 | 647.00 | 501.00 | 262.00 | |
| Assets | 343.00 | 360.00 | 393.00 | 721.00 | 503.00 | 327.00 | 332.00 | 597.00 | 655.00 | 1,422.00 | 1,885.00 | 2,137.00 | 2,616.00 | 3,071.00 | 2,942.00 | |
| Accounts Receivables (AR) | - - | - - | - - | 27.00 | 8.00 | - - | - - | -37.00 | -40.00 | -85.00 | 43.00 | -42.00 | -122.00 | 66.00 | -22.00 | |
| Inventory | - - | - - | - - | - - | 2.00 | 2.00 | 2.00 | 3.00 | 6.00 | 9.00 | 12.00 | 20.00 | 27.00 | 33.00 | 17.00 | |
| Short Term Investments | 116.00 | 65.00 | 120.00 | 241.00 | 138.00 | 63.00 | 25.00 | 268.00 | 204.00 | 378.00 | 585.00 | 887.00 | 819.00 | 807.00 | 732.00 | |
| Other Current Assets | 15.00 | 14.00 | 4.00 | 18.00 | 17.00 | 15.00 | 3.00 | 47.00 | 9.00 | 15.00 | 26.00 | 57.00 | 57.00 | 62.00 | 67.00 | |
|
Non Current
|
113.00 | 177.00 | 164.00 | 288.00 | 236.00 | 160.00 | 153.00 | 126.00 | 170.00 | 525.00 | 874.00 | 691.00 | 781.00 | 1,452.00 | 1,624.00 | |
| Property, Plant, Equipment (Net) | 29.00 | 15.00 | 8.00 | 6.00 | 4.00 | 2.00 | 1.00 | 2.00 | 25.00 | 56.00 | 90.00 | 67.00 | 104.00 | 401.00 | 470.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | 63.00 | - - | - - | - - | - - | - - | - - | - - | - - | |
| Goodwill | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 | |
| Long Term Investments | 17.00 | 93.00 | 89.00 | 182.00 | 144.00 | 81.00 | 83.00 | 55.00 | 64.00 | 157.00 | 536.00 | 332.00 | 371.00 | 756.00 | 728.00 | |
| Other Non Current Assets | 2.00 | 4.00 | 2.00 | 36.00 | 23.00 | 13.00 | 4.00 | 5.00 | 16.00 | 3.00 | 11.00 | 71.00 | 131.00 | - - | - - | |
| Liabilities | 507.00 | 589.00 | 302.00 | 424.00 | 437.00 | 442.00 | 436.00 | 508.00 | 370.00 | 134.00 | 199.00 | 258.00 | 405.00 | 583.00 | 678.00 | |
|
Current
|
207.00 | 199.00 | 92.00 | 81.00 | 87.00 | 171.00 | 52.00 | 270.00 | 115.00 | 105.00 | 142.00 | 204.00 | 337.00 | 324.00 | 394.00 | |
| Accounts Payable | - - | -9.00 | -5.00 | 6.00 | 8.00 | -13.00 | -1.00 | - - | 3.00 | - - | 44.00 | 51.00 | 55.00 | 25.00 | 53.00 | |
| Short Term Debt | 39.00 | 37.00 | 4.00 | 13.00 | 11.00 | 99.00 | - - | 189.00 | 57.00 | 56.00 | 2.00 | 3.00 | -8.00 | 17.00 | 25.00 | |
| Deferred Revenue | 103.00 | 100.00 | 41.00 | 16.00 | 1.00 | 2.00 | - - | 19.00 | 31.00 | 15.00 | 106.00 | 1.00 | 8.00 | 6.00 | 5.00 | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 57.00 | 59.00 | 43.00 | 47.00 | 65.00 | 63.00 | 45.00 | 55.00 | 16.00 | 21.00 | 21.00 | 176.00 | 313.00 | 267.00 | 329.00 | |
|
Non Current
|
300.00 | 389.00 | 210.00 | 342.00 | 349.00 | 270.00 | 384.00 | 237.00 | 255.00 | 29.00 | 56.00 | 53.00 | 68.00 | 258.00 | 284.00 | |
| Long Term Debt | 40.00 | 170.00 | 176.00 | 322.00 | 335.00 | 262.00 | 381.00 | - - | 14.00 | 12.00 | 48.00 | 49.00 | 51.00 | 190.00 | 189.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | 14.00 | 12.00 | 50.00 | 49.00 | 51.00 | 190.00 | 189.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | - - | - - | -14.00 | 1.00 | 9.00 | 10.00 | - - | - - | 54.00 | |
| Other Non Current Liabilities | 17.00 | 15.00 | 17.00 | 20.00 | 13.00 | 8.00 | 2.00 | - - | 16.00 | - - | -6.00 | -9.00 | 8.00 | 61.00 | 34.00 | |
| Equity | -163.00 | -228.00 | 90.00 | 296.00 | 66.00 | -114.00 | -104.00 | 89.00 | 284.00 | 1,287.00 | 1,685.00 | 1,879.00 | 2,210.00 | 2,488.00 | 2,263.00 | |
| Stockholders' Equity | -163.00 | -228.00 | 90.00 | 296.00 | 66.00 | -114.00 | -104.00 | 89.00 | 284.00 | 1,287.00 | 1,685.00 | 1,879.00 | 2,210.00 | 2,488.00 | 2,263.00 | |
| Retained Earnings | -1,089.00 | -1,182.00 | -1,106.00 | -1,254.00 | -1,498.00 | -1,767.00 | -1,937.00 | -1,983.00 | -1,829.00 | -880.00 | -559.00 | -447.00 | -216.00 | -34.00 | -173.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | 1,983.00 | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -135.00 | -92.00 | 75.00 | -147.00 | -244.00 | -268.00 | -169.00 | -70.00 | 154.00 | 690.00 | 321.00 | 111.00 | 231.00 | 182.00 | 207.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 925.00 | 953.00 | 1,196.00 | 1,550.00 | 1,564.00 | 1,652.00 | 1,832.00 | 89.00 | 2,114.00 | 2,168.00 | 2,241.00 | 2,321.00 | 2,427.00 | 2,536.00 | 2,440.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 3.00 | 4.00 | - - | -14.00 | -3.00 |